Creo Medical (GB:CREO) has released an update.
Creo Medical Group PLC, a pioneer in minimally invasive surgical endoscopy, will unveil its full year results for 2023 on May 15, 2024. Accompanying the announcement, a live presentation by executives will be made available to shareholders and analysts through the Investor Meet Company platform, where participants can engage with questions. The company continues to innovate in electrosurgical devices, aiming to enhance patient outcomes with its unique CROMA technology powered by Kamaptive.
For further insights into GB:CREO stock, check out TipRanks’ Stock Analysis page.
